Newsroom
  • May 31 , 2021

    Exploring CAR T-cell therapy to treat breast cancer

    Peter Mac researchers are developing a potential new way to make CAR T-cell therapy more effective against breast cancer and other solid cancers.
    Read more
  • May 26 , 2021

    New biochip technology for pharma research

    In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples.
    Read more
  • May 20 , 2021

    New biosensor developed to aid early diagnosis of breast cancer

    A team of Spanish researchers have developed, at the laboratory level, a prototype of a new biosensor to help detect breast cancer in its earliest stages. One of the team coordinators has been Ramón Martínez Máñez, a professor at the Universitat Politècnica de València (UPV) and the scientific director of the Networking Biomedical Research Centre in Bioengin
    Read more
  • January 20 , 2021

    Chinese Scientists Develop Gene Therapy that Could Delay Aging

    Scientists in Beijing have developed a new gene therapy which can reverse some of the effects of aging in mice and extend their lifespans, findings which may one day contribute to similar treatment for humans.
    Read more
  • December 25 , 2020

    How Did Innovent Achieve the 2 year Anniversary of Its First Drug Approval to a Market Value of Over $100 billion?

    Innovent began its journey in 2011 and its mission is to develop, manufacture and commercialize high-quality innovative medicines for the treatment of cancer and other major diseases. On October 31, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited and has achieved many milestones since then. On December 24, 2020, Innoven
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us